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Identification of the immunogens responsible for the production of pathogenic
autoantibodies is a major problem in the field of autoimmunity . In the principal
diseases that are thought to involve autoimmunization, rheumatoid arthritis, type
I diabetes, and multiple sclerosis are examples, the instigating stimulus is unknown .
Another example of the gap in our knowledge of disease-causing immunogens can
be found in SLE. The characteristic autoantibody of lupus binds to double-strand
(ds) DNA yet this nucleic acid antigen is barely immunogenic, even in lupus-prone
MRL-lpr/lpr mice (1) . Certain bacterial DNAs can elicit anti-dsDNA antibodies in
normal mice, butthoseantibodies and the spontaneouslyproduced anti-DNA anti-
bodies of SLE have different serological specificities (2). By contrast with the poor
immunogenicity of mammalian dsDNA, other forms of DNA, such as Z-DNA (a
double-strand molecule with a leftward spiraling helix instead of the right-handed
helical structure of dsDNA), elicit brisk immune responses in MLR-lpr/lpr mice as
well as in normal mice and rabbits (1, 3) . The lack of immunogenicity of exogenous
dsDNA does not disprove the participation of endogenous DNA in the origins of
anti-DNA antibodies, however. Cell nuclei, for example, might release a form of
dsDNA that is peculiarly immunogenic in patients with SLE .
In addition to nucleic acids, several polypeptides associated with uridine-rich small
nuclear ribonucleoprotein (snRNP) particles are also important autoantigens in SLE .
Patients with SLE and associated diseases (mixed connective tissue disease, sclero-
derma, rheumatoid arthritis, and Sjogren's syndrome) produce two categories of
autoantibodies against these particles: anti-RNP antibodies, whichbind theUl snRNP-
specific polypeptides 70 kD, A, andC, andanti-Sm antibodies, which bind to ashared
epitope in the B', B, andD snRNP polypeptides (4) . Anti-RNP autoantibodies, ac-
cording to one hypothesis, originate from the release of snRNP antigens from the
nuclei ofdead or injured cells (5) . The finding that normal mice respond to immuni-
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zation with a Ul RNP polypeptide (6) supports the view that endogenous nuclear
autoantigens can be immunogenic. However, this idea does not explain why the usual
daily turnover of nucleated cells does not elicit anti-RNP autoantibodies in normal
subjects. The observations that some mAbs can bind to both DNA and RNP (7),
and that anti-DNA and anti-RNP antibodies can share the same idiotypic marker
(8), suggest a link between anti-DNA and anti-RNP antibodies.
In this paper we report evidence that autoantibodies against U1 RNP, dsDNA,
and ssDNA can be elicited in normal mice by a purified Ig light chain. The third
hypervariable region of this light chain has two remarkable features: (a) it specifies
an idiotype that is a component ofa network of anti-DNA and anti-snRNP autoan-
tibodies in MRL-lpr/1pr mice, and (b) of its 9 amino acids, a sequence ofseven residues
has strong homology to a sequence in the U1 RNP autoantigen. This model system
demonstrates how autoantibodies can arise by au.toimmunization with idiotypes that
mimic autoantigens. It also identifies an amino acid sequence with the capacity of
eliciting anti-DNA antibodies.
Materials and Methods
Preparation ofRabbitAnti-Id-28/12.
￿
A rabbit was immunized subcutaneously with 150 ug
of affinity-purified mAb 28/12 in CFA and then boosted biweekly three times with 100 hg
of the antibody in IFA. Sera that contained the highest anti 28/12 activity were pooled and
made specific for the immunizing idiotype by repeated adsorptions on Sepharose 4B coupled
to pooled mouse Igs (TEPC 183, MOPC 104E, UPC 10, FLOPC, and MOPC 141, all pur-
chased from Litton Bionetics, Inc., Charleston, SC). The purified rabbit anti-28/12 was used
in a dilution of 1 :2,000. With that dilution on the solidphase, 200 JAI of biotin-labeled mAb
28/12 gave an OD4os of 0.600 within 20 min. The purified anti-28/12 did not bind to light
chains F, G, and 105 (see below).
DetectionofId-28/12.
￿
Polystyrene plates (Immulon II; Dynatech Laboratories, Inc., Alex-
andria, VA) were coated with 50 pl rabbit anti-28/12 antiidiotype diluted 1 :2,000 in 0.05 M
borate buffer, pH 8.6, and blocked with 3 % BSA in PBS. PBS containing 1 % BSA and 0.05%
Tween was used to dilute labeled and unlabeled antibodies. 251A1 ofbiotin-labeled mAb 28/12
(0.1 lAg/ml) (9), at a concentration corresponding to 50% maximal binding to the antiidio-
type reagent, was incubated on the plate together with the test antibody for 1 h at 37°C.
After three washes in PBSIBSA/Tween, avidin-alkaline phosphatase (Boehringer Mannheim
Biochemicals, Indianapolis, IN) was added and the bound enzymatic activity measured.
AntigenBinding .
￿
DNA and SmRNP binding by ELISA, Western blots, and liquid phase
competition assays were conducted as described in detail elsewhere (9). The snRNP antigens
were affinity purified from rabbit thymus extract on a mAb 28/12-Sepharose 4B column (9).
DNASequence ofLight Chain G.
￿
Total RNA was isolated from hybridoma cellswith guani-
dine isothiocyanate, and polyadenylated mRNAwas prepared by passage over oligo(dt)-cel-
lulose. cDNA,produced as previously described (10) with a 17-nucleotide 5' Cu region primer
(TGGATGGTGGGAAGATG) was ligated into M13-mp18 and plaques were screened with
a 32P-labeled 3 kb probe obtained from S. Lewis and D. Baltimore (11). Positive clones were
sequenced by the dideoxy method (12).
Immunization of Mice.
￿
Light chain G was affinity purified on a goat anti-mouse IgG-
Sepharose 4B chain and cross-linked to KLH with 0.25% glutaraldehyde. BALB/c mice (6 wk
old) were injected three times intraperitoneally with 10 hg of light chain G conjugated to
40 hg KLH in RIBI adjuvant (RIBI Immunochemical Research, Hamilton, MT) at 15-d
intervals. Control animals were given adjuvant alone or MOPC 104E in adjuvant in the same
schedule.
AntipeptideAntibodies.
￿
Purified synthetic peptides corresponding to the CDR3 of light
chain G, to residues 117-123 plus flanking residues of Ul RNP and to the CDR3 of mAb
R16.7 were a gift from Dr. Mai ChangKuo (Immulogic Pharmaceutical Corp., Cambridge,MA). For detection of anti-peptide antibodies in serum, Immunolon II plates were coated
overnight at 40C with 5 ttg/ml of peptide in PBS. The plates were blocked with PBS con-
taining 3 17o BSA and 3% nonfat dry milk. Mouseserum diluted in PBS containing 2 % nonfat
dry milk was added to the peptide-coated plate and incubated for 2 h at 37°C. After washing,
alkaline phosphatase goat anti-mouse IgG was added, the plates were incubated overnight
at 4°C, and bound enzymatic activity was measured. For competitive assays, dilutions of
serum corresponding to 50% maximal binding to peptide LCG G were incubated for 1 h
at 37'C with increasing amounts ofinhibitor peptide and transferred to a coated and blocked
plate. The remainder of the assay was carried out as described above.
Results
Definitions ofAb1 andAb-2.
￿
The experiments reported here originated from studies
of an idiotypic marker of MRL-116r/lpr anti-DNA antibodies termed Id-H130. A sub-
stantial fraction of serum anti-DNA antibodies in that strain bear the H130 idio-
type, but the majority of Id-H130+ antibodies do not bind to DNA (13). To define
the antigen-binding specificities of the latter, hybridomas derived from MRL-lpr/lpr
mice were screened for Id-H130 and the Id-H130+ antibodies were then tested to
exclude antibodies that bound to either ssDNA or dsDNA. Of the group of mono-
clonal antibodies identified in this manner, Id-H130+ mAb 28/12 was selected for
further study because ofits specificity for snRNP antigens (9). This mAb is of addi-
tional interest because it was found to be an anti-idiotype against 63/411 unselected
MRL-lpr/lpr rnAb (Koizumi, T., A. Puccetti, P. Migliorini, K. J. Barrett, R. S.
Schwartz, manuscript in preparation). We will refer to mAb 28/12 as antibody-1 (Ab-1)
and to the latter set of antibody-2 (Ab-2).
Light Chains ofAb-2.
￿
Three hybridomas (F, G, and 105) in the antibody-2 panel
were found to produce only light chain dimers: the hybridoma products reacted with
anti-rc serum, but not with anti-P, or anti--y chain antisera; only a 28-kD light chain
band was present on SDS-PAGE of the Igs; and there was selective absence of Cp.
and Cy mRNA (data not shown). Biotin-labeled mAb 28/12 bound quantitatively
to each of the three light chains (Fig. 1 A); the possibility that the MOPC 21 light
chain, produced in small amounts by the NS1, fusion partner, entered into those
reactions is unlikely because biotin-labeled mAb 28/12 does not bind to MOPC 21
(9). Each ofthe threelight chains inhibited the binding ofbiotin-labeled mAb 28/12
to a rabbit anti-28/12 idiotype in liquid phase competition assays (Fig. 1 B). These
FIGURE 1.
￿
(A) Direct binding
assay of the ability of biotin-
labeled mAb 28/12 to bind to
solidphase(1 ug/ml) lightchain
dimers G, 105, andF. (B)Inhi-
bition of binding of biotin-
labeled mAb 28/12 to rabbit
anti-Id-28/12 by lightchains G,
F, and105. Biotin-labeled 28/12
Io Ioo at aconcentration correspond-
Inhibitor (mg/ml)
￿
Inhibitor Wg/rnl)
￿
ingto50% maximalbindingto
theantiidiotype reagent wasin-
cubated with lightchains for 1 hat 37°C andtransferred to Imulon II plates coated with rabbit anti-Id-
28/12; After1 hincubation at 37°C, avidin-alkaline phosphatase was added, andthebound enzymatic
activity was developed with fi-nitrophenyl phosphate.
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FIGURE 2.
￿
Inhibition ofbinding ofbiotin-labeled
28/12 to snRNP by light chains. Biotin-labeled 28/12
was incubated for 1 h at 37°C with light chains and
then transferred to Immulon II plates coated with
affinity-purified nucleoprotein antigens (2.5 kg/ml).
Inhibition was detected as described in A.
results indicate that the light chain contains a major component ofthe Ab-2 idio-
tope recognized by mAb 28/12.
Aremarkable feature ofthe Ab-2 panel recognized by mAb 28/12 is that almost
one-third ofits membersare, like mAb 28/12 itself, anti-snRNP antibodies(Koizumi,
T, et al., manuscript in preparation). This suggested the possibility that some of
the Ab-2s we studied might contain a structure, perhaps in theirlight chains, that
resembles the snRNP antigen to which mAb 28/12 binds. To test this hypothesis,
wedetermined whetherthelightchains F, G, and 105could competeagainstsnRNP
autoantigens for binding to mAb 28/12. Fig. 2 shows the result ofthis experiment:
all threelight chains inhibited thebindingofmAb 28/12 to purified snRNP antigens
in a liquid phase assay.
The Amino Acid Sequence of Light Chain G.
￿
To investigate the structural basis of
idiotypic and autoantigen-mimicking properties of Ab-2 light chains, the nucleic
acids encoding the variable region oflight chain G were sequenced and compared
with databanks ofsequenced genes and proteins. Two ofthe related sequences were
ofsubstantial interest: the light chain ofR16.7, a mouse anti-arsonate antibody, and
the light chain ofMOPC 173, a mouse myeloma protein (14, 15). They are shown,
with the deduced amino acid sequence oflight chain G, in Fig. 3. The VL regions
ofR16.7 and light chain G are identical except for two framework residues at posi-
tions 80 and 87, but their CDR3s differ considerably. By contrast, the CDR3s and
framework regions oftheVL regions ofMOPC 173 and light chain Gare identical,
whereas their first two hypervariable regions differ. It is unlikely that the CDR1,
CDR2, or frameworks specify the idiotype oflight chain G since R16.7 does not
bind to mAb 28/12. MOPC 173 does bind to 28/12, however (Fig. 4 A). Further-
more, MOPC 173 was found to compete in a liquid phase assay with purified RNP
for binding to 28/12 (Fig. 4 B). This evidence suggests that the relevant idiotypic
and immunochemical properties oflight chain G are specified by its CDR3, either
as a linear sequence or in a conformation made up of the CDR3 and some other
part of the variable region of the light chain.
The interest in light chain G was heightened by the homology of a region ofits
CDR3 and an adjoining residue of its framework 4 with residues 117-123 within
the RNA binding domain of the human U1 RNP polypeptide (16):
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FIGURE 3 .
￿
The deduced amino acid sequence of light chain G compared with amino acid se-
quences of the light chains ofMOPC 173 and R16.7 . The three complementarity determining
regions are enclosed in boxes .
Immunogenic Properties ofLightChainG .
￿
To test the biological implications of these
immunochemical and structural findings, weimmunized 6-wk-old BALB/c mice with
immunoaffinity-purified lightchain G. If the autoantigen-mimicking idiotype oflight
chainG (Ab-2) is biologically relevant it should, in principle, evoke the production
of antibodies with a resemblance to Ab-1, the anti-snRNP 28/12mAb (16) . Groups
of control mice that were not injected, injected with adjuvant alone, or immunized
with an adjuvant mixture containing 10 hgMOPC 104E, an IgM antidextranmAb
that does not bind to any snRNP antigen or to DNA, were also tested . Fig. 5 A
shows that anti-RNP antibodies developed in all BALB/c miceimmunizedwith light
chain G. The anti-RNP antibodies appeared in relatively high titers within 4wk
after immunization and remained high for at least 3mo. None of the control mice
produced such autoantibodies . Fig. 5Bshows Western blots ofserum obtained from
BALB/c mice before and afterimmunization with lightchain G. Pre-immune serum
contained no detectable anti-snRNP antibodies, whereas serum obtained after im-
munization reactedwith a 70-kDRNA polypeptide, consistent with 70 kDU1 RNP,
and an unidentified 52-kD band . Somehuman anti-RNP sera have also been noted
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FIGURE 4.
￿
(A) Binding of biotin-labeled MOPC 173 to mAb 28/12 (solid phase) . No binding
wasobserved with 10 Wg/ml of R16.7 (solid dot) . (B) Inhibition ofbinding of biotin-labeled mAb
28/12 tosnRNP antigens (solid phase) by affinity-purifiedMOPC 173 . Neither R16.7 norMOPC
104 inhibited the binding.1924
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FIGURE 5 .
￿
(A) Production ofanti-RNP antibodies by mice immunized with light chain G. The
animals received three intraperitoneal injections of the light chain (10pg conjugated to 40 lAg
ofkeyhole limpet hemocyanin) in RIBI adjuvant at 15-d intervals . Preimmunization antibody
levels are shown at time 0 ; subsequent bleedings were obtained 4, 6, and 12 wk after the last
injection . Bars represent themean + SE ofserum antibody activity . All experimental mice (black
bars) produced anti-RNP antibodies . That group consisted ofthree animals in which the initial
observations were made plus five mice in which the results were reproduced. The injected con-
trols (15 mice) were given either RIBI adjuvant alone or MOPC 104E plus adjuvant in thesame
schedule as the experimental groups . Results for all 15 control mice were pooled . ELISA was
performed with a 1 :200 dilution of serum and purified snRNP antigens . (B) Western blots of
affinity-purified snRNP antigens probedwith serum from mice injected withlight chain G. (Lanes
1-3) Serum from three mice 4 wk after the last injection of the light chain . (Lanes 4-6) serum
from thesame animals before immunization . Theupper arrow points to aMADRNPpolypep-
tide antigen ; the lower arrow shows a 52-kD band, probably adegradation product ofthe 70-kD
antigen. (C) Anti-ssDNAantibodies in serum ofmice immunized with light chain G . The serum
samples shown in A were tested for anti-DNA antibodies with a direct ELISA assay .
to bind a 52-kD band in affinity-purifiedRNPpreparations (Reichlin,M., personal
communication) . Whether this band contains a distinct antigen or a breakdown
product of the 70-kD Ul polypeptide is unknown .
Peptide-binding Antibodies in Mice Immunized with Light Chain G.
￿
To evaluate fur-
ther the immunogenic potential of theCDR3 oflight chain G, sera from mice im-
munized with the light chain were assayed for reactivity against the three synthetic
peptides shown in Fig. 6C. TheLCGpeptide (peptide 1) corresponds to theCDR3
and adjoining framework residues of light chain G ; the RNP peptide (peptide 2)PUCCETTI ET AL .
￿
1925
FIGURE 6 .
￿
(A) Reaction ofmAb8B, produced by ahybridomaobtained from aBALB/c mouse
immunized with light chain G, with snRNP antigens. (Inset) Speckled nuclear fluorescence (HEP-2
cells) typical of anti-RNP antibodies, produced bymAb8B . (B) Reaction ofmAb 21/6, also from
a BALB/c mouse immunized with light chain G, to nucleic acid antigens . Note the reaction with
dsDNA in this liquid phase competition assay. The strong binding to poly(dT) is typical of lupus
anti-DNA mAbs . (C) Binding of serum antibodies from mice immunized with light chainGto
synthetic peptides correspondingto theCDR3 of light chain G (open bars) and to residues 117-123
plus flanking residues of Ul RNP (hatched bars), but not to a control peptide, the CDR3 of anti-
body R 16.7 (black bars) . For each pair the left bar is the mean + SE ofpreimmunization serum
and the right bar is the mean + SE for serum obtained 12 wk after the last injection of light
chainG. (D) Liquid phase competition assays ofanti-peptide antibodies from amouseimmunized
with light chain G. Aliquots ofaserum dilution corresponding to 50% maximalbinding to the
solid-phase binding to theLCGpeptide were incubatedwith the three peptides ; subsequent steps
were carried out as in A except that the second-step antibody wasan alkaline phosphatase-goat
anti-mouse Ig .
corresponds to the region in Ul RNP with a sequence homology to theCDR3 of
light chain G; R16.7, the control peptide (peptide 3), corresponds to the CDR3 of
the lightchain of antiarsonate antibody R16.7 . Allmiceimmunized with lightchain
G produced serum antibodies that bound to the LCG and RNP peptides ; no anti-
bodies against the control peptide were detected (Fig. 6 C) . The specificity of these
results wasconfirmed in 6/7 sera by cross-competitive inhibition assays of the three
synthetic peptides, a representative example of which is shown in Fig . 6 D. These
findings demonstrate that theCDR3 oflight chain G contains an immunogenic re-1926
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gion capable of stimulating normal mice to produce antibodies against an amino
acid sequence in the NH2-terminal region of the U1 RNP autoantigen. It is notable
that the region in U1 RNP that is homologous to the CDR3 oflight chain Goccurs
in a domain containing a major antigenic determinant for human anti-RNP anti-
bodies (17).
Anti-DNA Antibodies in Mice Immunizedwith Light Chain G.
￿
Besides its structural
similarity to a region of the 70 kD U1 RNP autoantigen, the CDR3 of light chain
G also contains an idiotype recognized by mAb 28/12 (Fig. 1). In theory (18), this
idiotype has thepotential to stimulatethe production ofantibodies with the idiotype
ofmAb 28/12, butwith specificities other than anti-snRNP. Since mAb 28/12 shares
an idiotypic marker with some anti-DNA antibodies (9), we sought anti-DNA anti-
bodies in the animals immunized with light chain G. After receiving light chain
G, all eight mice produced anti-ss DNA antibodies within 3 mo; two animals also
hadantibodies againstdsDNA in theirserum. Themaximum response wasobserved
about 2 mo after peak levels of anti-RNP antibodies were reached. Anti-DNA anti-
bodies were not found in any of the control animals (Fig. 5 C).
Binding Properties ofmAbsfrom Mice Immunized with Light Chain G.
￿
Direct valida-
tion of the specificities of the serum autoantibodies was sought by analysis ofmAbs
from animals that had produced antibodies against RNP, ssDNA, and dsDNA. Hy-
bridomas were prepared from three such mice, and 127 mAbs were found to have
the following specificities: anti-RNP (n = 16), anti-ss DNA (n = 31), anti-dsDNA
(n = 4); anti-RNP + anti-ssDNA (n = 58). mAbs ofeach ofthose specificities were
obtained from all three animals. Examples of the binding properties oftwo of these
mAbs are given in Fig. 6 A for an anti-RNP mAb (mAb 8B) and in Fig. 6 B for
a mAb with reactivity against both ssDNA and dsDNA (mAb 21/6). The inset of
Fig. 6A shows the typical speckled nuclearstaining patternofanti-RNP antibodies,
produced by antibody 8B. Of the 127 mAbs, 18, including the antibody shown in
Fig. 6 B, shared an idiotypic marker with the original 28/12 anti-snRNP antibody.
A detailed idiotypic and structural study ofthis group of antibodies will be the sub-
ject of a separate report.
Discussion
Ourfinding that the CDR3 of an Ab-2 is structurally homologous to an autoan-
tigen has several precedents. Fougereau's group (19) analyzed an idiotypic network
evoked in mice by immunization with a random copolymer of glutamine, alanine
and tyrosine (GAT): Ag -->Ab-1 -Ab-2 -Ab-3 . The Ab-Is and Ab-3sthat expressed
the dominant anti-GAT idiotype used closely related VH and Vrc genes. The D re-
gion of the Ab-2s contained either a Tyr-Tyr-Glu or aGlu-GluTyr sequence, which
are characteristic of the major epitopes of GAT. This D region may therefore con-
tain an internal image of theimmunogen. Bona et al. (20) have described an antiidi-
otype that reacted with both an idiotype of a monoclonal IgG human rheumatoid
factor and the Fc fragment of human IgG. They called this doubly reactive anti-
idiotype an epibody, an antibody that recognizes both an idiotype and an epitope
on the original antigen. Subsequently, Chen et al. (21) found a second antibody ex-
ample of an epibody; an antiserum against a synthetic peptide corresponding to
the first hypervariable region of the X light chain of a human rheumatoid factorPUCCETTI ET AL .
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was found to bind pooled normal human IgG . This crossreaction involving theVL
region of an Ig and the Fc domain of IgG was attributed to a Ser-Ser-Ser peptide
in both the ,y chains of IgG and the light chain of the rheumatoid factor. Bruck et
al . (22) reported that an Ab-2 against an antireovirus hemagglutinin antibody con-
tained an amino acid sequence thatwas also present in the viral antigen. Van Cleave
et al. (23) described two mouse monoclonal Ab-2s that mimic the rabbit Ig al allo-
type . TheCDR2s ofthe heavychains ofboth antibodies contained sequences corre-
sponding to the presumed mAb internal image, but in opposite orientation . Syn-
thetic peptides corresponding to the internal imagecompletely inhibited the binding
of rabbit Ig to the anti-al antibody despite their opposite orientations .
Atopic ofconsiderable current interest is whetheridiotypic networks caninfluence
the process of autoirnmunization . Such networks may modulate the production of
autoantibodies via auto-antiidiotypes, or they might actually induce autoantibodies
if the variable region of an Ab-2 imitates the structure or contact region of an au-
toantigen (the internal image effect, reference 24) . The induction, by immunization
of antiidiotypic antibodies that mimic self structures, has been reported by others
(25-28). An example of this phenomenon is the development of myasthenia gravis
in rabbits immunized with Bis ,, a synthetic compound that binds to theacetylcho-
line receptor. Ab-2s against anti-BisQantibodies (Ab-1) in the serum of the affected
rabbitshadproperties of antiacetylcholine receptor antibodies (29) . Anotherexample
was found in mice immunized with a human anti-DNA mAb. The animals pro-
duced antiidiotypic antibodies against thehumanIg and also anti-antiidiotypes that
hadanti-DNA and otherautoantibody activity (30) . In thismodeltheinjected anti-
body probably triggered a cascade of idiotypes which culminated in a population
of autoantibodies . Iribe et al . (31) have shown that injection of a rabbit antiidiotype
against a murine anti-type II collagen mAb evoked the production of anti-type II
collagen antibodies in DBA mice .
The Ig lightchainwe studiedhastwo remarkable features: it contains amolecular
mimic ofanuclearRNP autoantigen, andthevery region ofthat mimicry functions
as an idiotype. We propose that these dual properties can explain the ability of the
light chain to elicit both anti-RNP and anti-DNA antibodies : the former probably
arise from the structural similarities to Ul RNP, whereas the latter might originate
from perturbation of idiotypic networks .
The autoantibodies produced by MRL-lpr/lpr mice have been attributed to poly-
clonal B cell activation, an important abnormalityin that strain and in other lupus-
pronemice (32) . However, structural analysis has shownthatIgG MRL-lpr/lpr anti-
DNA antibodies arise from alimitednumber ofB cell clones byaprocessof somatic
mutation, a result consistent with aselective mechanism driven by antigen (33) . Our
data provide a basis for reconciling three puzzling aspects of the origins of anti-
DNA antibodies : the lack of immunogenicity ofDNA, the evidence for an antigen-
driven mechanism, and the prominence of polyclonal B cell activation . Nonspecific
expansion oftheB cellcompartmentcould increase the probability of the expression
of autoantigen-mimicking idiotypes, which might in turn participate - in the selec-
tion of autoantibody-producing clones . The activation of B cells by peptide frag-
ments ofVregion (idiopeptides) is predictedby the"peptide self"modelofKourilsky
et al . (34) .1928
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The finding that the region with sequence homology to an antigenic region of
the Ul 70-kDRNP in light chain G resides in its somatically generated CDR3 has
another interesting implication . Autoantigen-mimicking idiotypes arising as a re-
sult of somatic rearrangements and insertion ofN sequences in variable region genes
might explain some of the perplexing, apparently random events in many autoim-
mune diseases. The production of anti-Sm antibodies in only -30% of patients with
lupus is an example (35) . Anti-Sm antibodies develop in a similar minority ofMRL-
lpr/lpr mice even though they are an almost genetically uniform inbred strain . A
thorough analysis has disclosed that stochastic events probably determine the produc-
tion ofanti-Sm autoantibodies in MRL-lpr/7pr mice ; there was no evidence for genetic,
environmental, gender, or parental influences on the tendency ofindividual animals
to produce those antibodies (36) . Whether somatically generated idiotypes could
provide the stimulus that leads to pathogenic autoantibodies and tissue lesions is
now under investigation .
Summary
Autoantibodies against the 70-kD Ul RNP nucleoprotein autoantigen and DNA
were elicited in normalBALB/c mice with a purified Ig light chain . This light chain,
derived from a lupus-prone MRL-lpr/lpr mouse, has two distinctive properties : it
contains an idiotypic marker recognized by a monoclonal MRL-1pr/lpr anti-snRNP
autoantibody, and theamino acid sequence of its third hypervariable region (CDR3)
is homologous to a sequence in an antigenic region of the 70-kD U1 RNP polypep-
tide. The results demonstrate that an Ig idiotype that mimics an autoantigen can
induce autoimmunization .
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